The SmartTrack® validation study. Changing the game in regulatory approvals for generic OINDPs
Key takeaways from ISAM 2026: Nanopharm’s Lucas Silva on inhaled biologics, digital health and regulatory science in nasal and pulmonary drug delivery.
ISAM 2026: Looking Forward to the Next Chapter for Inhaled and Nasal Drug Delivery
Key takeaways from ISAM 2026: Nanopharm’s Lucas Silva on inhaled biologics, digital health and regulatory science in nasal and pulmonary drug delivery.